References
- Necus J, Sinha N, Smith FE, et al. White matter microstructural properties in bipolar disorder in relationship to the spatial distribution of lithium in the brain. J Affect Disord. 2019;253:224–231.
- Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord. 2014;2:15.
- Nortje G, Stein DJ, Radua J, et al. Systematic review and voxel-based meta-analysis of diffusion tensor imaging studies in bipolar disorder. J Affect Disord. 2013;150(2):192–200.
- Lope-Piedrafita S. Diffusion tensor imaging (DTI). Methods Mol Biol. 2018;1718:103–116.
- Lyoo IK, Dager SR, Kim JE, et al. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology. 2010;35(8):1743–1750.
- Moore GJ, Cortese BM, Glitz DA, et al. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J Clin Psychiatry. 2009;70(5):699–705.
- Usher J, Menzel P, Schneider-Axmann T, et al. Increased right amygdala volume in lithium-treated patients with bipolar I disorder. Acta Psychiatr Scand. 2010;121(2):119–124.
- Abramovic L, Boks MPM, Vreeker A, et al. The association of antipsychotic medication and lithium with brain measures in patients with bipolar disorder. Eur Neuropsychopharmacol. 2016;26(11):1741–1751.
- Bearden CE, Thompson PM, Dalwani M, et al. Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry. 2007;62(1):7–16.
- Germaná C, Kempton MJ, Sarnicola A, et al. The effects of lithium and anticonvulsants on brain structure in bipolar disorder. Acta Psychiatr Scand. 2010;122(6):481–487.
- Hafeman DM, Chang KD, Garrett AS, et al. Effects of medication on neuroimaging findings in bipolar disorder: an updated review. Bipolar Disord. 2012;14(4):375–410.
- Hibar DP, Westlye LT, Doan NT, et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA bipolar disorder working group. Mol Psychiatry. 2018;23(4):932–942.
- Singh MK, Chang KD. The neural effects of psychotropic medications in children and adolescents. Child Adolesc Psychiatr Clin N Am. 2012;21(4):753–771.
- 14. Abramovic L, Boks MPM, Vreeker A, et al. White matter disruptions in patients with bipolar disorder. Eur Neuropsychopharmacol. 2018;28(6):743–751.
- Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6(7):e1000097.
- Kafantaris V, Spritzer L, Doshi V, et al. Changes in white matter microstructure predict lithium response in adolescents with bipolar disorder. Bipolar Disord. 2017;19(7):587–594.
- Benedetti F, Bollettini I, Barberi I, et al. Lithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorder. Neuropsychopharmacology. 2013;38(2):313–327.
- Benedetti F, Poletti S, Locatelli C, et al. A Homer 1 gene variant influences brain structure and function, lithium effects on white matter, and antidepressant response in bipolar disorder: a multimodal genetic imaging study. Prog Neuropsychopharmacol Biol Psychiatry. 2018;81:88–95.
- Berk M, Dandash O, Daglas R, et al. Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume. Transl Psychiatry. 2017;7(1):e1011.
- Wells GA, Shea B, O'Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Clin Epidemol. 2019; available at http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
- Besson JA, Henderson JG, Foreman EI, et al. An NMR study of lithium responding manic depressive patients. Magn Reson Imaging. 1987;5(4):273–277.
- Emsell L, Langan C, Van Hecke W, et al. White matter differences in euthymic bipolar I disorder: a combined magnetic resonance imaging and diffusion tensor imaging voxel-based study. Bipolar Disord. 2013;15(4):365–376.
- Foley SF, Bracher-Smith M, Tansey KE, et al. Fractional anisotropy of the uncinate fasciculus and cingulum in bipolar disorder type I, type II, unaffected siblings and healthy controls. Br J Psychiatry. 2018;213(3):548–554.
- Furlan R, Melloni E, Finardi A, et al. Natural killer cells protect white matter integrity in bipolar disorder. Brain Behav Immun. 2019;81:410–421.
- Gildengers AG, Butters MA, Aizenstein HJ, et al. Longer lithium exposure is associated with better white matter integrity in older adults with bipolar disorder. Bipolar Disord. 2015;17(3):248–256.
- Haarman BCM, Riemersma-Van der Lek RF, Burger H, et al. Diffusion tensor imaging in euthymic bipolar disorder - a tract-based spatial statistics study. J Affect Disord. 2016;203:281–291.
- Macritchie KA, Lloyd AJ, Bastin ME, et al. White matter microstructural abnormalities in euthymic bipolar disorder. Br J Psychiatry. 2010;196(1):52–58.
- Versace A, Almeida JRC, Hassel S, et al. Elevated left and reduced right orbitomedial prefrontal fractional anisotropy in adults with bipolar disorder revealed by tract-based spatial statistics. Arch Gen Psychiatry. 2008;65(9):1041–1052.
- Benedetti F, Absinta M, Rocca MA, et al. Tract-specific white matter structural disruption in patients with bipolar disorder. Bipolar Disord. 2011;13(4):414–424.
- Alda M. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics. Mol Psychiatry. 2015;20(6):661–670.
- Forlenza OV, De-Paula VJ, Diniz BS. Neuroprotective effects of lithium: implications for the treatment of Alzheimer’s disease and related neurodegenerative disorders. ACS Chem Neurosci. 2014;5(6):443–450.
- Rybakowski JK, Suwalska A, Hajek T. Clinical perspectives of lithium’s neuroprotective effect. Pharmacopsychiatry. 2018;51(5):194–199.
- Hajek T, Weiner MW. Neuroprotective effects of lithium in human brain? Food for thought. Curr Alzheimer Res. 2016;13(8):862–872.
- Kessing LV, Forman JL, Andersen PK. Does lithium protect against dementia? Bipolar Disord. 2010;12(1):87–94.
- Kessing LV, Søndergård L, Forman JL, et al. Lithium treatment and risk of dementia. Arch Gen Psychiatry. 2008;65(11):1331–1335.
- Dupont RM, Jernigan TL, Butters N, et al. Subcortical abnormalities detected in bipolar affective disorder using magnetic resonance imaging: clinical and neuropsychological significance. Arch Gen Psychiatry. 1990;47(1):55–59.
- James A, Hough M, James S, et al. Structural brain and neuropsychometric changes associated with pediatric bipolar disorder with psychosis. Bipolar Disord. 2011;13(1):16–27.
- Krabbendam L, Honig A, Wiersma J, et al. Cognitive dysfunctions and white matter lesions in patients with bipolar disorder in remission. Acta Psychiatr Scand. 2000;101(4):274–280.
- Linke J, King AV, Poupon C, et al. Impaired anatomical connectivity and related executive functions: differentiating vulnerability and disease marker in bipolar disorder. Biol Psychiatry. 2013;74(12):908–916.
- Oertel-Knöchel V, Reinke B, Alves G, et al. Frontal white matter alterations are associated with executive cognitive function in euthymic bipolar patients. J Affect Disord. 2014;155:223–233.
- Poletti S, Bollettini I, Mazza E, et al. Cognitive performances associate with measures of white matter integrity in bipolar disorder. J Affect Disord. 2015;174:342–352.